Citations

Showing 10 of 108104 citations.

Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center
Munoz-Casabella, Amanda, Wahner-Roedler, Dietlind L., Croghan, Ivana T. , Petterson, Tanya M., Fuehrer, Debbie L., Bauer, Brent A. , Munoz-Casabella, Amanda, Wahner-Roedler, Dietlind L., Croghan, Ivana T , Petterson, Tanya M., Fuehrer, Debbie L., Bauer, Brent A

Mayo Clinic

Global Advances in Health and Medicine | March 25, 2022 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1177/2164957x221078543 | PMID 35360507 Get It

Background Glioblastoma multiforme (GBM) is among the most aggressive and lethal tumors, with a median survival of 12–15 months. Many patients use complementary and integrative medicine (CIM) therapies to supplement their cancer treatment. Objective To determine the prevalence of CIM use and identify the most frequently used types of CIM in a cohort of patients with GBM seen at a tertiary care medical center in the United States. Methods An anonymous survey was mailed through the US Postal Service from August 1, 2019, through February 21, 2020, to patients with GBM. Results A total of 346 surveys were mailed, and 146 responses (42%) were received. The median age of respondents was 61 years (range, 52–68 years), and 85 (58%) were male. Most patients had undergone surgery (90%), chemotherapy (96%), and radiotherapy (95%). The median time from diagnosis of GBM to survey participation was 18 months (range, 12–31 months). Most respondents (81%) used some form of CIM, most frequently meditation (22%), relaxation and other stress management techniques (19%), chiropractic therapy (16%), and acupuncture (12%). Compared with men, women more commonly meditated (32% vs 16%; P = .046) and practiced yoga (20% vs 6%; P = .04). We observed age-based differences, with younger patients more commonly meditating, practicing relaxation and stress management techniques, and receiving chiropractic therapy ( P < .05 for all). Conclusions Providers should encourage patients with GBM to discuss their interest in CIM therapies and guide them to evidence-based treatments that may help improve their quality of life.
Over 20 years of declining Medicare reimbursement for spine surgeons: a temporal and geographic analysis from 2000 to 2021
Haglin, Jack M. , Zabat, Michelle A. , Richter, Kent R. , McQuivey, Kade S. , Godzik, Jakub , Eltorai, Adam E. M. , Patel, Naresh P. , Daniels, Alan H.

Mayo Clinic

Journal of Neurosurgery: Spine | March 25, 2022 | Volume: 37 | Issue: 3 | Pages: 452-459

10.3171/2022.2.spine211368 | PMID 35334463 Get It

OBJECTIVE Procedural reimbursement for spine surgery has changed drastically over the past 20 years. A comprehensive understanding of these trends is important as major changes in reimbursement models of spine surgery continue to evolve within various spine specialties as well as broader national healthcare policy. In this study the authors evaluated the monetary trends in Medicare reimbursement rates for the 15 most common spinal surgery procedures from 2000 to 2021. METHODS The National Surgery Quality Improvement Project database (2019) was queried to determine the 15 most commonly performed spine surgery procedures. The Current Procedural Terminology (CPT) codes for each of these procedures were obtained from the Physician Fee Schedule Look-Up Tool from the Centers for Medicare and Medicaid Services, and comprehensive reimbursement data for each code were extracted. Changes in Medicare reimbursement rates were calculated and averaged for each procedure as both raw percent changes and percent changes adjusted for inflation to 2021 US dollars (USD) based on the consumer price index (CPI). The adjusted R2 value, the compound annual growth rate (CAGR), and both the average annual and the total percent change in reimbursement were calculated based on these adjusted trends for all included procedures. RESULTS After adjustment for inflation, average reimbursement for all procedures decreased by 33.8% from 2000 to 2021. The greatest mean decrease was seen in anterior cervical arthrodesis (−38.7%), while the smallest mean decrease was in vertebral body excision (−17.1%). From 2000 to 2021, the adjusted reimbursement rate for all included procedures decreased by an average of 1.9% each year, with an average R2 value of 0.69. CONCLUSIONS This is the first study to evaluate monetary trends in Medicare reimbursement for spine surgery procedures. After adjusting for inflation, Medicare reimbursement for the 15 most commonly performed spine procedures has steadily decreased from 2000 to 2021. Increased awareness of these trends and the forces driving them will be critical in the coming years as negotiations regarding reimbursement models continue to unfold. Greater understanding of spine surgery reimbursement among policy makers, hospitals, and surgeons will be important to ensure continued access to quality surgical spine care in the United States.
Differences in postoperative quality of life in young, early elderly, and late elderly patients undergoing surgical treatment for degenerative cervical myelopathy
Croci, Davide M., Sherrod, Brandon, Alvi, Mohammed Ali, Mummaneni, Praveen V., Chan, Andrew K., Bydon, Mohamad, Glassman, Steven D., Foley, Kevin T., Potts, Eric A., Shaffrey, Mark E., Coric, Domagoj, Knightly, John J., Park, Paul, Wang, Michael Y., Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L., Than, Khoi D., Gottfried, Oren N., Shaffrey, Christopher I., Virk, Michael S., Bisson, Erica F., Park, Paul , Alvi, Mohammed Ali , Alvi, Mohammed Ali , Croci, Davide M., Sherrod, Brandon, Alvi, Mohammed Ali, Mummaneni, Praveen V., Chan, Andrew K., Bydon, Mohamad, Glassman, Steven D., Foley, Kevin T., Potts, Eric A., Shaffrey, Mark E., Coric, Domagoj, Knightly, John J., Park, Paul, Wang, Michael Y., Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L., Than, Khoi D., Gottfried, Oren N., Shaffrey, Christopher I., Virk, Michael S., Bisson, Erica F.

Mayo Clinic

Journal of Neurosurgery: Spine | March 25, 2022 | Volume: 37 | Issue: 3 | Pages: 339-349

10.3171/2022.1.spine211157 | PMID 35276658 Get It

OBJECTIVE Cervical spondylotic myelopathy (CSM) is a common progressive spine disorder affecting predominantly middle-aged and elderly populations. With increasing life expectancy, the incidence of CSM is expected to rise further. The outcomes of elderly patients undergoing CSM surgery and especially their quality of life (QOL) postoperatively remain undetermined. This study retrospectively reviewed patients to identify baseline differences and validated postoperative patient-reported outcome (PRO) measures in elderly patients undergoing CSM surgery. METHODS The multi-institutional, neurosurgery-specific NeuroPoint Quality Outcomes Database was queried to identify CSM patients treated surgically at the 14 highest-volume sites from January 2016 to December 2018. Patients were divided into three groups: young (< 65 years), early elderly (65–74 years), and late elderly (≥ 75 years). Demographic and PRO measures (Neck Disability Index [NDI] score, modified Japanese Orthopaedic Association [mJOA] score, EQ-5D score, EQ-5D visual analog scale [VAS] score, arm pain VAS, and neck pain VAS) were compared among the groups at baseline and 3 and 12 months postoperatively. RESULTS A total of 1151 patients were identified: 691 patients (60%) in the young, 331 patients (28.7%) in the early elderly, and 129 patients (11.2%) in the late elderly groups. At baseline, younger patients presented with worse NDI scores (p < 0.001) and lower EQ-5D VAS (p = 0.004) and EQ-5D (p < 0.001) scores compared with early and late elderly patients. No differences among age groups were found in the mJOA score. An improvement of all QOL scores was noted in all age groups. On unadjusted analysis at 3 months, younger patients had greater improvement in arm pain VAS, NDI, and EQ-5D VAS compared with early and late elderly patients. At 12 months, the same changes were seen, but on adjusted analysis, there were no differences in PROs between the age groups. CONCLUSIONS The authors’ results indicate that elderly patients undergoing CSM surgery achieved QOL outcomes that were equivalent to those of younger patients at the 12-month follow-up.
Vein of Marshall alcohol ablation for dormant pulmonary vein conduction: A case report
Janga, Chaitra , Madhavan, Malini , Siontis, Konstantinos C. , Killu, Ammar M.

Mayo Clinic

Journal of Cardiovascular Electrophysiology | March 25, 2022 | Volume: 33 | Issue: 5 | Pages: 1070-1071

10.1111/jce.15466 | PMID 35332624 Get It

AbstractWe report a case of alcohol ablation into a vein of Marshall for recurrent dormant conduction into the pulmonary veins with adenosine testing in a patient where two prior ablation attempts failed to isolate the left vein.
Donation after circulatory death transplant outcomes using livers recovered by local surgeons
Macdonough, Elizabeth , Pont, Kylie , Valenti, Kristi , Lizaola‐Mayo, Blanca , Brooks, Abigail , Das, Devika , Heilman, Raymond L. , Mathur, Amit K. , Hewitt, Winston R. , Moss, Adyr A. , Aqel, Bashar , Reddy, Kunam S. , Jadlowiec, Caroline , Macdonough, Elizabeth , Pont, Kylie , Valenti, Kristi , Lizaola-Mayo, Blanca , Brooks, Abigail , Das, Devika , Heilman, Raymond , Mathur, Amit , Hewitt, Winston , Moss, Adyr , Aqel, Bashar A. , Reddy, Kunam S , Jadlowiec, Caroline C.

Mayo Clinic

Liver Transplantation | March 25, 2022 | Volume: 28 | Issue: 11 | Pages: 1726-1734

10.1002/lt.26461 | PMID 35332655 Get It

Abstract Donation after circulatory death (DCD) liver transplantation (LT) outcomes have been attributed to multiple variables, including procurement surgeon recovery techniques. Outcomes of 196 DCD LTs at Mayo Clinic Arizona were analyzed based on graft recovery by a surgeon from our center (transplant procurement team [TPT]) versus a local procurement surgeon (non‐TPT [NTPT]). A standard recovery technique was used for all TPT livers. The recovery technique used by the NTPT was left to the discretion of that surgeon. A total of 129 (65.8%) grafts were recovered by our TPT, 67 (34.2%) by the NTPT. Recipient age (p = 0.43), Model for End‐Stage Liver Disease score (median 17 vs. 18; p = 0.22), and donor warm ischemia time (median 21.0 vs. 21.5; p = 0.86) were similar between the TPT and NTPT groups. NTPT livers had longer cold ischemia times (6.5 vs. 5.0 median hours; p < 0.001). Early allograft dysfunction (80.6% vs. 76.1%; p = 0.42) and primary nonfunction (0.8% vs. 0.0%; p = 0.47) were similar. Ischemic cholangiopathy (IC) treated with endoscopy occurred in 18.6% and 11.9% of TPT and NTPT grafts (p = 0.23). At last follow‐up, approximately half of those requiring endoscopy were undergoing a stent‐free trial (58.3% TPT; 50.0% NTPT; p = 0.68). IC requiring re‐LT in the first year occurred in 0.8% (n = 1) of TPT and 3.0% (n = 2) of NTPT grafts (p = 0.23). There were no differences in patient (hazard ratio [HR], 1.95; 95% confidence interval [CI], 0.76–5.03; p = 0.23) or graft (HR, 1.99; 95% CI, 0.98–4.09; p = 0.10) survival rates. Graft survival at 1 year was 91.5% for TPT grafts and 95.5% for NTPT grafts. Excellent outcomes can be achieved using NTPT for the recovery of DCD livers. There may be an opportunity to expand the use of DCD livers in the United States by increasing the use of NTPT.
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score
Pai, Rish K. , Hogan, Malcolm , Zou, Guangyong , Adeyi, Oyedele , Anstee, Quentin M. , Aqel, Bashar , Behling, Cynthia , Carey, Elizabeth J. , Feagan, Brian G. , McFarlane, Stefanie C., Noureddin, Mazen , Younossi, Zobair M. , Loomba, Rohit , Ratziu, Vlad , Anstee, Quentin M , Corey, Kathleen , Ma, C , Ratziu, Vlad , Loomba, Rohit , Ratziu, Vlad , Adeyi, Oyedele , Zou, Guangyong , Jairath, Vipul , Aqel, Bashar A. , Clouston, Andrew Donald , Corey, Kathleen E. , Kleiner, David Erwin , Ma, Christopher , Valasek, Mark A. , Harrison, Stephen A.

Mayo Clinic

Hepatology | March 25, 2022 | Volume: 76 | Issue: 4 | Pages: 1150-1163

10.1002/hep.32475 | PMID 35332569 Get It

Abstract Background and Aims The NASH Clinical Research Network histologic scoring system, the gold‐standard NASH histology assessment for clinical trials, has demonstrated intrarater and interrater variability. An expert panel in a previous systematic Research and Development/University of California Los Angeles (RAND/UCLA) study determined that existing histologic scoring systems do not fully capture NASH disease activity and fibrosis, and standardized definitions of histologic features are needed. We evaluated the reliability of existing and alternate histologic measures and their correlations with a disease activity visual analog scale to propose optimal components for an expanded NAFLD activity score (NAS). Approach and Results Four liver pathologists who were involved in the prior RAND/UCLA study underwent standardized training and multiple discussions with the goal of improving agreement. They were blinded to clinical information and scored histologic measures twice, ≥2 weeks apart, for 40 liver biopsies representing the full spectrum of NAFLD. Index intraclass correlation coefficient (ICC) estimates demonstrated intrarater (0.80–0.85) and interrater (0.60–0.72) reliability. Hepatocyte ballooning items had similar interrater ICCs (0.68–0.79), including those extending scores from 0–2 to 0–4. Steatosis measures (interrater ICCs, 0.72–0.80) correlated poorly with disease activity. Correlations with disease activity were largest for hepatocyte ballooning and Mallory‐Denk bodies (MDBs), with both used to develop the expanded NAS (intrarater ICC, 0.90; interrater ICC, 0.80). Fibrosis measures had ICCs of 0.70–0.87. Conclusions After extensive preparation among a group of experienced pathologists, we demonstrated improved reliability of multiple existing histologic NAFLD indices and fibrosis staging systems. Hepatocyte ballooning and MDBs most strongly correlated with disease activity and were used for the expanded NAS. Further validation including evaluation of responsiveness is required.
Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma
Kumar, Shaji , Medhekar, Rohan , Pei, Huiling , Lefèbvre, Patrick , Kaila, Shuchita, He, Jianming , Lafeuille, Marie‐Hélène, Cortoos, Annelore, Londhe, Anil, Mavros, Panagiotis , Lin, Thomas S., Usmani, Saad Z. , Usmani, Saad , Jakubowiak, Andrzej

Mayo Clinic

The Oncologist | March 25, 2022 | Volume: 27 | Issue: 7 | Pages: e589-e596

10.1093/oncolo/oyac067 | PMID 35462406 Get It

Abstract Background Patients with high-risk, newly diagnosed multiple myeloma (HR-NDMM) who are ineligible for autologous stem cell transplant (ASCT) have limited first-line treatment options. Recent meta-analyses evaluating the impact of incorporating daratumumab in the backbone regimen on progression-free survival (PFS) have found mixed results in these patients. Materials and Methods A pooled analysis of patient-level data for ASCT-ineligible patients with HR-NDMM [ie, del(17p), t(4;14), t(14;16)] from the MAIA and ALCYONE trials; stratified by study identifier and adjusting for cytogenetic abnormality subtype, baseline performance status, International Staging System stage, myeloma type, and renal impairment; was conducted. Impact of daratumumab on PFS and rates of complete response or better (≥CR), minimal residual disease (MRD)-negative CR, very good partial response or better (≥VGPR), and overall response (ORR) was compared to control. Results Among 101 patients in the daratumumab and 89 patients in the control cohort, median follow-up was 43.7 months. Daratumumab reduced the risk of progression or death by 41% (adjusted hazard ratio for PFS [95% confidence interval (CI)] = 0.59 [0.41-0.85]) versus control. At 36 months, the estimated proportion of patients who did not progress and were still alive was 41.3% in the daratumumab and 19.9% in the control cohort. Rates of ≥CR (41.6% vs. 22.5%), MRD-negative CR (24.8% vs. 5.6%), ≥VGPR (75.2% vs. 46.1%), and ORR (92.1% vs. 74.2%) were higher for daratumumab versus control. Conclusion These findings demonstrate that incorporation of daratumumab in frontline treatment regimens reduced the risk of progression or death and improved response rates among ASCT-ineligible HR-NDMM patients.
A framework for examining patient attitudes regarding applications of artificial intelligence in healthcare
Richardson, Jordan , Smith, Cambray , Barry, Barbara , Sharp, Richard R. , Richardson, Jordan P , Curtis, Susan , Pacyna, Joel, Zhu, Xuan , Barry, Barbara , Sharp, Richard R , Pacyna, Joel E.

Mayo Clinic

DIGITAL HEALTH | March 25, 2022 | Volume: 8 | Issue: No issue available | Pages: 205520762210890

10.1177/20552076221089084 | PMID 35355806 Get It

Background While use of artificial intelligence (AI) in healthcare is increasing, little is known about how patients view healthcare AI. Characterizing patient attitudes and beliefs about healthcare AI and the factors that lead to these attitudes can help ensure patient values are in close alignment with the implementation of these new technologies. Methods We conducted 15 focus groups with adult patients who had a recent primary care visit at a large academic health center. Using modified grounded theory, focus-group data was analyzed for themes related to the formation of attitudes and beliefs about healthcare AI. Results When evaluating AI in healthcare, we found that patients draw on a variety of factors to contextualize these new technologies including previous experiences of illness, interactions with health systems and established health technologies, comfort with other information technology, and other personal experiences. We found that these experiences informed normative and cultural beliefs about the values and goals of healthcare technologies that patients applied when engaging with AI. The results of this study form the basis for a theoretical framework for understanding patient orientation to applications of AI in healthcare, highlighting a number of specific social, health, and technological experiences that will likely shape patient opinions about future healthcare AI applications. Conclusions Understanding the basis of patient attitudes and beliefs about healthcare AI is a crucial first step in effective patient engagement and education. The theoretical framework we present provides a foundation for future studies examining patient opinions about applications of AI in healthcare.
Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications
Preuss, Kiersten , Thach, Nate, Baine, Michael J. , Zhang, Chi , Du, Huijing, Yu, Hongfeng , Zheng, Dandan , Baine, Michael , Yu, Hongfeng , Zheng, Dandan , Liang, Xiaoying , Chen, Justin Albert , Lin, Chi H. , Hollingsworth, Michael A.

Mayo Clinic

Cancers | March 25, 2022 | Volume: 14 | Issue: 7 | Pages: 1654

10.3390/cancers14071654 | PMID 35406426 Get It

As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized medicine utilizing cutting-edge multi-omics data holds potential for major breakthroughs in tackling this critical problem. Radiomics and deep learning, two trendy quantitative imaging methods that take advantage of data science and modern medical imaging, have shown increasing promise in advancing the precision management of pancreatic cancer via diagnosing of precursor diseases, early detection, accurate diagnosis, and treatment personalization and optimization. Radiomics employs manually-crafted features, while deep learning applies computer-generated automatic features. These two methods aim to mine hidden information in medical images that is missed by conventional radiology and gain insights by systematically comparing the quantitative image information across different patients in order to characterize unique imaging phenotypes. Both methods have been studied and applied in various pancreatic cancer clinical applications. In this review, we begin with an introduction to the clinical problems and the technology. After providing technical overviews of the two methods, this review focuses on the current progress of clinical applications in precancerous lesion diagnosis, pancreatic cancer detection and diagnosis, prognosis prediction, treatment stratification, and radiogenomics. The limitations of current studies and methods are discussed, along with future directions. With better standardization and optimization of the workflow from image acquisition to analysis and with larger and especially prospective high-quality datasets, radiomics and deep learning methods could show real hope in the battle against pancreatic cancer through big data-based high-precision personalization.
Integrative Hedonic and Homeostatic Food Intake Regulation by the Central Nervous System: Insights from Neuroimaging
Campos, Alejandro , Port, John D. , Campos, Alejandro , Port, John D , Acosta, Andrés

Mayo Clinic

Brain Sciences | March 25, 2022 | Volume: 12 | Issue: 4 | Pages: 431

10.3390/brainsci12040431 | PMID 35447963 Get It

Food intake regulation in humans is a complex process controlled by the dynamic interaction of homeostatic and hedonic systems. Homeostatic regulation is controlled by appetitive signals from the gut, adipose tissue, and the vagus nerve, while conscious and unconscious reward processes orchestrate hedonic regulation. On the one hand, sight, smell, taste, and texture perception deliver potent food-related feedback to the central nervous system (CNS) and influence brain areas related to food reward. On the other hand, macronutrient composition stimulates the release of appetite signals from the gut, which are translated in the CNS into unconscious reward processes. This multi-level regulation process of food intake shapes and regulates human ingestive behavior. Identifying the interface between hormones, neurotransmitters, and brain areas is critical to advance our understanding of conditions like obesity and develop better therapeutical interventions. Neuroimaging studies allow us to take a glance into the central nervous system (CNS) while these processes take place. This review focuses on the available neuroimaging evidence to describe this interaction between the homeostatic and hedonic components in human food intake regulation.